BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 12 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,000 | +1200.0% | 325 | +62.5% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 200 | -60.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 500 | +400.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -98.1% | 0.00% | – |
| Q3 2018 | $29,000 | -67.0% | 5,200 | -60.6% | 0.00% | – |
| Q2 2018 | $88,000 | +60.0% | 13,200 | +29.4% | 0.00% | – |
| Q1 2018 | $55,000 | -71.4% | 10,200 | -71.6% | 0.00% | – |
| Q4 2017 | $192,000 | 0.0% | 35,886 | +33.4% | 0.00% | – |
| Q3 2017 | $192,000 | +3740.0% | 26,900 | +4383.3% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 600 | -33.3% | 0.00% | – |
| Q1 2017 | $5,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Investment Advisors, LLC | 17,000 | $99,000 | 0.03% |
| Edge Wealth Management LLC | 10,000 | $2,000 | 0.00% |
| Citadel Advisors | 30,583 | $177,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,236 | $83,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $1,000 | 0.00% |
| DEUTSCHE BANK AG\ | 900 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 23 | $0 | 0.00% |